A Multicenter, Double-Blind, Randomized, Vehicle-Controlled Phase 1/2a Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 Gel in Subjects With Plaque Psoriasis
Phase of Trial: Phase I/II
Latest Information Update: 19 Jul 2019
Price : $35 *
At a glance
- Drugs ESR-114 (Primary)
- Indications Plaque psoriasis
- Focus Proof of concept; Therapeutic Use
- Sponsors Escalier Biosciences
- 16 Jul 2019 Status changed from active, no longer recruiting to completed.
- 15 Apr 2019 Status changed from recruiting to active, no longer recruiting.
- 22 Aug 2018 New trial record